Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP1.7881 in Moderate-to-Severe Atopic Dermatitis
2022-502045-10-00Phase 2Completed
- Sponsor
- Bioprojet
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing BP1.7881 with Placebo (2 arms). Started May 2023; status: completed.
02
Drugs
BP1.7881
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2022-502045-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502045-10-00.